Oxygen Biotherapeutics, Inc. Reports Financial Results for Fiscal Year 2012
MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a development stage biomedical company focused on developing oxygen-carrying intravenous and topical products, today announced results for the fiscal year (FY) ended April 30, 2012.